Table 3 Benefit analysis of systemic lymph node dissections in diagnosing lymph node invasion
Cagiannos | 2012-Briganti | Partin | MSKCC | 2018-Briganti | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Criterion (%) | ≥ 5 | ≥ 5 | ≥ 5 | ≥ 5 | ≥ 7 | |||||
Above threshold | Y | N | Y | N | Y | N | Y | N | Y | N |
LNI | 8 | 10 | 17 | 1 | 9 | 9 | 18 | 0 | 1 | 1 |
no LNI | 18 | 273 | 117 | 174 | 38 | 253 | 152 | 139 | 33 | 39 |
RR | 8.7 | (3.8; 20.1) | 22.2 | (3.0; 164.7) | 5.6 | (2.3; 13.3) | 30.3 | (1.8; 498.2) | 1.2 | (0.1; 18.1) |
NNT | 3.7 | 8.3 | 6.4 | 9.6 | 226.7 | |||||
Criterion (%) | > 1.5 | > 8.5 | > 1.5 | > 10.5 | > 9.75 | |||||
Above threshold | Y | N | Y | N | Y | N | Y | N | Y | N |
LNI | 13 | 5 | 6 | 2 | 10 | 8 | 6 | 12 | 1 | 1 |
no LNI | 203 | 88 | 68 | 223 | 152 | 139 | 62 | 229 | 12 | 60 |
RR | 1.12 | (0.41; 3.05) | 9.1 | (1.9; 44.2) | 1.1 | (0.5; 2.8) | 1.8 | (0.7; 4.5) | 4.7 | (0.3; 70.3) |
NNT | 155.7 | 13.9 | 136.9 | 26 | 16.5 | |||||